Research Notes

Monkey Knockout In an early step toward developing a potentially invaluable animal model, scientists, for the first time, have genetically modified a nonhuman primate (A.W. Chan et al., "Transgenic monkeys produced by retroviral gene transfer into mature oocytes," Science, 291:309-12, Jan. 12, 2001). Researchers at the Oregon Regional Primate Research Center at the Oregon Health Sciences University in Portland used a replication-incompetent retrovirus as a vector to deliver the gene for green f

Written byEugene Russo
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In an early step toward developing a potentially invaluable animal model, scientists, for the first time, have genetically modified a nonhuman primate (A.W. Chan et al., "Transgenic monkeys produced by retroviral gene transfer into mature oocytes," Science, 291:309-12, Jan. 12, 2001). Researchers at the Oregon Regional Primate Research Center at the Oregon Health Sciences University in Portland used a replication-incompetent retrovirus as a vector to deliver the gene for green fluorescent protein (GFP) into a rhesus monkey oocyte (a mature egg). According to lead author Anthony W.S. Chan, the procedure, in the works for two and a half years, is a tricky one. Oocytes are hard to come by, and relatively little is known about primate embryology. Of the 224 eggs fertilized, half of them developed; forty embryos were selected and placed into 20 surrogate monkey moms. Of the five successful pregnancies, there were three live births. But tests have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies